Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs "RICH"


Phase N/A Results N/A

Summary of Purpose

The true incidence and risks of intracranial hemorrhage (ICH) in patients on various antithrombotic treatments remain unknown. Here a nationwide study is conducted to investigate the risk for and incidence rates of ICH in users and non-users of various oral antithrombotic drugs in Norway between 2008 through 2014. Hopefully, this study will contribute to a more responsible prescription pattern of ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 April 2017.

1 May 2015 22 Jun 2015 1 Jan 2016 1 Jan 2016 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Case-Only
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample


Not available